Filing Details
- Accession Number:
- 0001179110-11-009694
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-15 18:30:37
- Reporting Period:
- 2011-06-14
- Filing Date:
- 2011-06-15
- Accepted Time:
- 2011-06-15 18:30:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1005201 | Depomed Inc | DEPO | Pharmaceutical Preparations (2834) | 943229046 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1420228 | Md Michael Sweeney | 1360 O' Brien Drive Menlo Park CA 94025 | Cmo And Vp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-06-14 | 4,470 | $8.18 | 3,163 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-06-15 | 1,385 | $8.40 | 1,778 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares were initially purchased under Depomed, Inc.'s 2004 Employee Stock Purchase Plan.
- The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.16 to $8.19. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
- The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.39 to $8.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
Billionaire Hedge Funds
